Raymond James & Associates Palatin Technologies Inc Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$0.98 - $1.64 $13,377 - $22,386	-13,650 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$0.67 - $1.01 $603 - $909	900 Added 7.06%	13,650 $13,000
Q4 2018 Feb 11, 2019	SELL	$0.63 - $1.0 $2,457 - $3,900	-3,900 Reduced 23.42%	12,750 $9,000
Q3 2018 Nov 14, 2018	BUY	$0.88 - $1.1 $14,652 - $18,315	16,650 New	16,650 $17,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.29M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.